Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$998 Sell
35
-35
-50% -$762 ﹤0.01% 1967
2026
Q1
$1.22K Sell
70
-1,278
-95% -$24.2K ﹤0.01% 1240
2025
Q4
$25.4K Buy
+1,348
New +$22.6K ﹤0.01% 908
2025
Q1
Sell
-382
Closed -$8.18K 1664
2024
Q4
$8.18K Sell
382
-490
-56% -$11.9K ﹤0.01% 1286
2024
Q3
$27.2K Buy
+872
New +$21.7K 0.01% 1004
2024
Q2
Sell
-113
Closed -$1.2K 1820
2024
Q1
$1.2K Buy
+113
New +$1.13K ﹤0.01% 1563
2023
Q2
Sell
-429
Closed -$3.92K 1093
2023
Q1
$3.92K Sell
429
-562
-57% -$7.19K ﹤0.01% 964
2022
Q4
$11.3K Buy
+991
New +$14.7K ﹤0.01% 579

Other funds holding CDNA

Quarry LP's CDNA Position: Q2 2026 in Review

Quarry LP reduced its CareDx (CDNA) stake by 50% in Q2 2026, selling an estimated $762 and leaving 35 shares worth $998. The position accounts for ﹤0.01% of the portfolio, ranked #1967.

Quarry LP first reported a position in CDNA in Q4 2022 and has held it in 8 quarters since. The position peaked at $27.2K in Q3 2024. 228 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Quarry LP held 35 shares of CareDx worth $998 as of Q2 2026.
  • Quarry LP sold 35 CareDx shares in Q2 2026, an estimated $762.
  • CareDx made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1967 holding.
  • Quarry LP first reported a position in CareDx in Q4 2022 and has held it in 8 quarters since.
  • Quarry LP's CareDx position peaked at $27.2K in Q3 2024.
  • 228 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.